Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$8.58 - $17.65 $1.56 Million - $3.21 Million
-181,857 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$10.17 - $18.96 $1.85 Million - $3.45 Million
181,857 New
181,857 $3.32 Million
Q4 2020

Feb 16, 2021

SELL
$18.13 - $25.18 $1.92 Million - $2.66 Million
-105,803 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$17.83 - $29.12 $1.89 Million - $3.08 Million
105,803 New
105,803 $2.23 Million

Others Institutions Holding OYST

About Oyster Point Pharma, Inc.


  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.